AstraZeneca buys heart firm Omthera for up to $443 million

[riky]

AstraZeneca buys heart firm Omthera for up to $443 million

By Ben Hirschler LONDON (Reuters) - AstraZeneca is to buy Omthera Pharmaceuticals for as much as $443 million to build up its cardiovascular drug business, a priority area for Britain's second-biggest drugmaker. The acquisition of the U.S.-based specialist in fish oil-derived medicine underscores a drive by new Chief Executive Pascal Soriot to revive AstraZeneca's fortunes through a series of bolt-on deals. It is his second purchase in the cardiovascular field, following the acquisition last month of AlphaCore Pharma, a small early-stage U.S. biotechnology company. ...

Source: You are not allowed to view links. Register or Login